Tscan Therapeutics Inc (TCRX) — Free Cash Flow Generation Index
Latest as of September 2023:
0.82x
Tscan Therapeutics Inc (TCRX) has a Free Cash Flow Generation Index of 0.82x as of September 2023. Free cash flow of $6.60 Million represents 1% of operating cash flow ($8.02 Million). Explore TCRX capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
0.82x
Free Cash Flow / Operating CF
Free Cash Flow
$6.60 Million
USD
Operating Cash Flow
$8.02 Million
USD
Capital Expenditures
$1.42 Million
USD
Annual Free Cash Flow Generation for Tscan Therapeutics Inc (None–None)
Year-by-year Free Cash Flow Generation Index for Tscan Therapeutics Inc. Check cash flow reinvestment rate of Tscan Therapeutics Inc to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (USD) | Operating CF | Capital Expenditures | YoY Change |
|---|
FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).